GlassScriptPhysician profile
Thomas Goodine
NPI 1366931354
$16,378.65
in general payments reported to CMS, 2019-2025
10 companies · $3,019 in 2025
The $3,019 reported for 2025 was more than what 76% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $125 · 2021: $50.86 · 2022: $1,545 · 2023: $681 · 2024: $458 · 2025: $3,019.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,397 · Travel and Lodging: $1,352 · Education: $409.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,396.57 |
| Travel and Lodging | $1,352.36 |
| Education | $408.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $5,862.50 | 2019-2023 | Evos |
| Arthrex, INC. | $4,763.37 | 2019 | |
| Stryker Corporation | $1,514.47 | 2020-2025 | Mako, Aequalis Perform Reversed, Aequalis |
| Zimmer Biomet Holdings, INC. | $1,465.07 | 2025 | Persona, Comprehensive Shoulder System, G7 |
| Impactortho, INC. | $1,323.53 | 2022-2023 | |
| Microport Orthopedics INC | $1,162.71 | 2022-2025 | Mpo Medial Pivot Knee |
| Davol INC. | $124.88 | 2024 | |
| Vericel Corporation | $66.97 | 2022-2024 | Maci |
| Depuy Synthes Sales INC. | $59.78 | 2025 | Milagro, Truespan Orthocord |
| Nalu Medical, INC. | $35.37 | 2024 | Nalu Neurostimulation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Goodine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.